Isotechnika, Vifor Pharma sign global development and commercialization ... pharmabiz.com “While the successful development of voclosporin for the prevention of kidney transplant rejection remains our primary focus, we believe the expansion of our platform beyond that indication via partnerships like this may help to unlock the drug's full ... |
